The University of Chicago Medicine, in partnership with the University of Chicago Division of Biological Sciences, sponsors graduate medical education (GME) programs. We offer more than 100 GME opportunities, including a broad range of residency and fellowship programs in more than 30 clinical departments. Graduate medical education programs focused on cancer research are listed below.
In addition to radiation oncology, the University of Chicago Medicine offers residencies in many departments including dermatology, internal medicine and urology, to name a few. Visit the graduate medical education website for a complete listing of residency programs.
Our nationally recognized residency program in Radiation Oncology meets all the requirements of the American Board of Radiology and is fully accredited by the American Medical Association’s Accreditation Council for Graduate Medical Education (ACGME). The four-year program provides students with hands-on experience through clinical training, seminars and conferences, and rotations and research.
The University of Chicago offers several accredited fellowship opportunities for doctors wishing to further specialize in a field of medicine after residency. Many of these graduate medical education fellowships can be pursued jointly.
The Department of Medicine offers an ACGME-accredited fellowship in Hematology/Oncology. Fellows can choose between a two- or three-year program that emphasizes research and education while providing excellent mentorship, outstanding scholarly opportunities, and ample protected time.
The American Board of Clinical Pharmacology (ABCP)-accredited Clinical Pharmacology and Pharmacogenomics fellowship offers training in personalized medicine, pharmacogenomics, new drug development, classical clinical pharmacology, genetics of drug abuse and clinical trial design. The mission of the two-year program is to train highly qualified individuals (PhD, MD, PharmD) for participation in a broad range of academic clinical pharmacology and pharmacogenomic activities.
The ACGME-accredited Geriatrics and Palliative Medicine fellowship offers a three- or four-year interdisciplinary program which satisfies all clinical training requirements for board eligibility in both disciplines. The Section of Hematology/Oncology accepts 6 new fellows per year for the three-year clinical program. The curriculum in geriatric oncology integrates training in both disciplines.
The Section of Pediatric Hematology/Oncology and Stem Cell Transplantation in the Department of Pediatrics at the University of Chicago offers a three-year Fellowship Program, accredited by the ACGME. The Fellowship Program trains pediatricians in the clinical discipline of Pediatric Hematology/Oncology and prepares them for a potential career in academic medicine and as independent investigators. Throughout the fellowship years, all fellows participate in an extensive group of educational programs.
In conjunction with NorthShore University HealthSystem, the University of Chicago Medicine facilitates a Gynecologic Oncology Fellowship Program. The three-year program admits one fellow per year and consists of one year of research and two clinical years, which are divided between the campuses of the University of Chicago Medicine in Chicago, Illinois and NorthShore University Health System in Evanston, Illinois.
The Surgical Oncology Fellowship Program at the University of Chicago is an ACGME-approved fellowship that is based at the University of Chicago Medicine and NorthShore University HealthSystem. The two-year program allows fellows to dedicate 20 months to clinical rotations and 4 months to research, and participants are strongly encouraged to take advantage of an additional 12 months of dedicated research time. The curriculum of the fellowship is independent and distinct from the General Surgery residency training program. This fellowship prepares surgeons to assume leadership in the multidisciplinary care of the cancer patient and to engage in high quality research. We seek to train the highest caliber surgeons to become leaders in surgical oncology.